As a practicing Neonatologist, member of the 180 Clinical Advisory Board, Dr. Liz Kennedy sees the impact of maternal opioid use in her Neonatology practice on a daily basis. Working on the border of TN and GA, her patients are too often babies suffering from Neonatal Abstinence Syndrome (NAS), which is 100% preventable. Dr. Kennedy serves a critical role as a physician, advising the leadership in the nuances of managing and treating babies with NAS, and she is passionate about helping prevent this condition from happening.
Dr. Kennedy is a graduate of Vanderbilt University and the University of Florida College of Medicine. She did her residency and fellowship at the University of Florida and is Board Certified in neonatology and a fellow of the American Academy of Pediatrics with a specialty in neonatology.
She holds a master’s degree in Business Administration from the University of Tennessee at Chattanooga and is a former faculty member of the University of Tennessee College of Medicine-Chattanooga Unit.